SRSF1 and glioblastoma: We tested the immunohistochemical expression of SRSF1 in a cohort of patients affected by GBM and other glial neoplasms, including 21 oligodendrogliomas, 15 ependymomas, 15 Pas, 5 SEGAs and 4 PXAs.